Skip to content

Evaluation of the effect of modified Xingpiyiwei Decoction combined with peck acupuncture on the prevention of metachronous early gastric cancer

Evaluation of the effect of modified Xingpiyiwei Decoction combined with peck acupuncture on the prevention of metachronous early gastric cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200006031
Enrollment
Unknown
Registered
2022-05-23
Start date
2022-06-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastric cancer

Interventions

Traditional medicine:peck acupuncture
Traditional medicine:Xingpiyiwei Decoction

Sponsors

Peking University First Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Between the ages of 40 and 70 years. (2) Surgical pathological criteria for early gastric cancer. (3) Breath test confirmed H. pylori as uninfected or post-decontamination status. (4) Not taking any type of post-operative gastric medication or currently off medication for more than 1 month. (5) Stable local residence with no plans to move within the last 2 years. (6) Conscious and capable of autonomous behaviour and can cooperate with the implementation of the intervention. (7) Consent to participate in this study.

Exclusion criteria

Exclusion criteria: (1) Patients with other systemic neoplastic disease or a history of neoplastic disease. (2) Patients with serious co-morbidities that may prevent safe participation in the intervention. (3) Patients who have had an acute serious cardiovascular or cerebrovascular event, severe trauma or major post-operative surgery within six months. (4) Patients with definite hepatic or renal insufficiency. (5) Patients who are pregnant and lactating, allergic and have a history of allergy to drug components. (6) Patients who have participated in other clinical interventional studies within the last 3 months.

Design outcomes

Primary

MeasureTime frame
OLGA Score;OLGIM Score;

Countries

China

Contacts

Public ContactRong Long
ronglong8@vip.sina.com18611582017

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026